[VRTX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
02-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 30.85%
YoY- 12.98%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 2,634,700 2,493,200 2,196,200 1,793,370 1,524,485 941,293 752,157 23.21%
PBT -3,391,200 1,161,500 1,024,400 -44,255 824,770 327,138 216,591 -
Tax 202,400 245,800 213,900 -111,179 -12,500 59,711 10,341 64.08%
NP -3,593,600 915,700 810,500 66,924 837,270 267,427 207,360 -
Tax Rate - -21.16% -20.88% - 1.52% -18.25% -4.77% -
Total Cost 6,228,300 1,577,500 1,385,700 1,726,446 687,215 673,866 544,797 50.03%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -136.40 36.73 36.90 3.73 54.92 28.41 27.57 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -13.92 3.55 3.17 0.26 3.22 1.04 0.82 -
EPS Diluted -13.92 3.52 3.13 0.26 3.18 1.03 0.80 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.